How do I resolve a CO-55 denial?

Review the 835 Healthcare Policy Identification Segment (loop 2110 Service Payment Information REF) if present on the remittance: This segment will identify the specific payer policy or clinical guideline used to classify the service as experimental/investigational Gather peer-reviewed literature, FDA approvals, clinical guidelines, or medical society position statements supporting the service as medically accepted standard of care: Experimental/investigational denials require clinical evidence that the procedure/treatment/drug has moved beyond investigational status for the specific indication treated Submit a formal appeal with clinical documentation, physician letter of medical necessity, and evidence that the service meets accepted medical practice standards: Address the specific policy cited by the payer and demonstrate why the service should be covered under the patient's benefits despite the experimental classification

835 Denial Combination

CO-55

Contractual Obligation · Claim-Level Adjustment

Medical Necessity

What This Combination Means

The payer has determined the service, treatment, or drug is experimental or investigational and is denying payment under the provider's contractual agreement. The provider is contractually obligated to write off the denied amount and cannot balance bill the patient, even though the denial is based on the payer's coverage policy rather than a fee schedule adjustment.

Financial Responsibility

provider writeoff

The provider must absorb the full cost as a contractual write-off. The patient has no financial liability for this experimental/investigational determination under the CO group code.

25%

Appeal Success

30-60 days (appeal process)

Avg. Resolution

Hard

Difficulty

Yes

Appealable

Step-by-Step Resolution

Steps tailored specifically to this CO-55 combination — not generic advice.

Appealable:Medical necessity denials based on experimental/investigational determinations are appealable with supporting clinical evidence demonstrating the service is medically accepted or necessary.

1
Review the 835 Healthcare Policy Identification Segment (loop 2110 Service Payment Information REF) if present on the remittance
This segment will identify the specific payer policy or clinical guideline used to classify the service as experimental/investigational
2
Gather peer-reviewed literature, FDA approvals, clinical guidelines, or medical society position statements supporting the service as medically accepted standard of care
Experimental/investigational denials require clinical evidence that the procedure/treatment/drug has moved beyond investigational status for the specific indication treated
3
Submit a formal appeal with clinical documentation, physician letter of medical necessity, and evidence that the service meets accepted medical practice standards
Address the specific policy cited by the payer and demonstrate why the service should be covered under the patient's benefits despite the experimental classification

Specialty Context

How CO-55 typically presents across different practice types.

Dental

May apply to emerging dental technologies, new implant systems, or investigational materials not yet accepted as standard practice by the payer's dental policy

Medical

Common for cutting-edge cancer treatments, gene therapies, new medical devices, off-label drug use, or procedures without sufficient clinical trial data in the payer's view

Behavioral Health

May affect novel therapies such as transcranial magnetic stimulation (TMS), ketamine treatment, or new pharmacological interventions not yet included in standard treatment protocols

Individual Code References

View the standalone definition for each code in this combination.

CARC 55

Need to resolve this denial?

Get a complete resolution plan with appeal guidance for this exact combination in seconds.

Generate a free resolution plan & appeal letter →

Synthesized from official definitions — not from training data

Was this helpful?

← Back to Combo Lookup Browse All Codes →